Progress towards agreement in reports of antibiotic sensitivity.
D002511:Cephalosporins / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003023:Cloxacillin / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D005672:Fusidic Acid / Q000494:pharmacology; D005839:Gentamicins / Q000494:pharmacology; D007612:Kanamycin / Q000494:pharmacology; D008034:Lincomycin / Q000494:pharmacology; D008712:Methicillin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests / Q000592:standards*; D009355:Neomycin / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D010403:Penicillin Resistance; D010405:Penicillinase / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D013210:Staphylococcus / Q000187:drug effects*; D013307:Streptomycin / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D002511:Cephalosporins; D005839:Gentamicins; D010406:Penicillins; D013449:Sulfonamides; D009675:Novobiocin; D007612:Kanamycin; D005672:Fusidic Acid; D004917:Erythromycin; D002701:Chloramphenicol; D008034:Lincomycin; D010405:Penicillinase; D013752:Tetracycline; D009355:Neomycin; D003023:Cloxacillin; D008712:Methicillin; D012293:Rifampin; D013307:Streptomycin